Sichuan Huiyu Pharmaceutical Co. Ltd. Class ASSE: 688553

Announcement on Voluntary Disclosure of Administration of the First Subject to the Phase 1 Clinical Trial of HY0001a for Injection

· Issued by Sichuan Huiyu Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Administration of the First Subject to the Phase 1 Clinical Trial of HY0001a for Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis